Haemonetics Earnings Preview: Get Ahead of the Analysts

Haemonetics (NYSE:HAE) will report earnings before markets open on Wednesday, May 1st. Haemonetics Corporation designs, manufactures, and markets automated blood processing systems. The Company’s products are for use in surgical blood salvage, blood component collections, and plasma collections. Haemonetics markets its products worldwide, primarily outside the United States.

Here is your Cheat Sheet to Haemonetics Earnings:

Earnings Expectations: Analysts expect earnings of $0.46 per share on revenues of $249.33 million. Currently, the company’s P/E ratio stands at 45.80.

Analyst Trends:

Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.43 and has not changed. For the current year, the average estimate is a profit of $1.69, which is the same as the estimate ninety days ago.

Earnings Trends:

Here’s how Haemonetics has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 516.44 597.88 645.43 676.69 727.84
Diluted EPS ($) 0.97 1.135 1.12 1.56 1.295

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 191.16 186.67 176.48 218.18 247.40
Diluted EPS ($) 0.36 0.3467 0.19 0.125 0.19

Past Performance:
Haemonetics has beat analyst estimates 2 times in the past four quarters. This is not consistent enough to get bullish yet.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)